Rocco Lagioia
About
In The Last Decade
Rocco Lagioia
45 papers receiving 774 citations
Peers
Comparison fields: 5 of 81
- Cardiology and Cardiovascular Medicine 530
- Hematology 194
- Complementary and alternative medicine 86
- Molecular Biology 79
- Genetics 78
Countries citing papers authored by Rocco Lagioia
This map shows the geographic impact of Rocco Lagioia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rocco Lagioia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rocco Lagioia more than expected).
Fields of papers citing papers by Rocco Lagioia
This network shows the impact of papers produced by Rocco Lagioia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rocco Lagioia. The network helps show where Rocco Lagioia may publish in the future.
Co-authorship network of co-authors of Rocco Lagioia
This figure shows the co-authorship network connecting the top 25 collaborators of Rocco Lagioia. A scholar is included among the top collaborators of Rocco Lagioia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rocco Lagioia. Rocco Lagioia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 2 | |
| 3 | 5 | |
| 4 | 2 | |
| 5 | 15 | |
| 6 | 25 | |
| 7 | 12 | |
| 8 | 19 | |
| 9 | 76 | |
| 10 | 219 | |
| 11 | Comparison between anti-ischaemic efficacy and drug plasma levels : amlodipine versus isosorbide-5-mononitrate trial | 2 |
| 12 | 25 | |
| 13 | Valore del consumo massimo di ossigeno durante esercizio per la stratificazione prognostica di pazienti con severa disfunzione sistolica del ventricolo sinistro. | 3 |
| 14 | 2 | |
| 15 | Ticlopidine treatment for patients with unstable angina at rest: A further analysis of the study of ticlopidine in unstable angina | 3 |
| 16 | EFFETTI ACUTI DELLA NISOLDIPINA A DIVERSI DOSAGGI NELL'ANGINA DA SFORZO STABILE | 1 |
| 17 | Gallopamil in the treatment of angina pectoris | 3 |
| 18 | EFFICACIA E DURATA D'AZIONE DEL GALLOPAMIL, IN UNICA SOMMINISTRAZIONE ORALE, NELL'ANGINA DA SFORZO STABILE. CONFRONTO CON PROPRANOLOLO E DILTIAZEM | 1 |
| 19 | Dose-response effectiveness of gallopamil for the treatment of chronic stable effort angina pectoris: Comparison with propranolol | 10 |
| 20 | RAPPORTO DOSE-EFFETTO E DURATA D'AZIONE DEL DILTIAZEM NELL'ANGINA DA SFORZO STABILE. CONFRONTO CON PROPRANOLOLO | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.